Clinical Trial Update: Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the combination of acitretin and efalizumab for chronic plaque psoriasis. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Acitretin (Acitretin)
• Efalizumab (efalizumab)

Snippet

Sponsor: Universita di Verona | Conditions: Chronic Plaque Psoriasis | Phase 4 | Status: UNKNOWN